Form 4: Ingredion CEO Sells Shares Under 10b5-1 Plan

Ingredion Inc.'s President and CEO, James P. Zallie, sold 33,597 shares of common stock for approximately $4.02 million under a pre-arranged 10b5-1 trading plan.

Summary

• James P. Zallie, President and CEO of Ingredion Inc. and a Director, sold 33,597 shares of the company's common stock.
• The transaction occurred on February 11, 2026, at a weighted average price of $119.66 per share, with prices ranging from $117.18 to $120.46.
• The total value of the shares sold is approximately $4,020,000.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 7, 2025.
• Following the transaction, Mr. Zallie directly beneficially owns a total of 123,696.579 shares of Ingredion Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is part of a pre-established 10b5-1 plan, which mitigates any negative interpretation typically associated with insider selling, as it is not based on new, non-public information.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information and is a routine part of executive financial planning.

Negatives

• An insider sale by the President and CEO, even under a 10b5-1 plan, reduces the executive's direct equity stake in the company.

Future Outlook

N/A

Industry Context

StockSavvy.ai notes that insider sales under 10b5-1 plans are common for executives to manage personal finances and diversify holdings without implying a negative outlook on the company's future. This is a routine disclosure for a large-cap company like Ingredion.

Stakeholder Impact

• Shareholders: Minor reduction in the CEO's direct equity stake, but the pre-planned nature of the sale under a 10b5-1 plan generally alleviates concerns about management's confidence in the company's future prospects.

Key Dates

Recommendation

The insider sale by the CEO was conducted under a pre-arranged 10b5-1 trading plan, which is a standard practice for executives to manage personal finances and diversify holdings. This type of transaction is generally considered neutral and does not typically signal a change in the company's fundamental outlook or warrant an immediate change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.

Keywords

Ingredion Inc, INGR, James P. Zallie, Insider Sale, Form 4, 10b5-1 Plan, CEO Stock Sale, Common Stock